VRNS Insider Sale: Guy Melamed Disposes 5,392 Shares via 10b5-1
Rhea-AI Filing Summary
Guy Melamed, identified as CFO and COO of Varonis Systems, Inc. (VRNS), reported two sales of common stock under a Rule 10b5-1 trading plan. On 08/28/2025 he sold 3,892 shares at a weighted average price of $59.52, leaving him with 413,605 shares. On 08/29/2025 he sold 1,500 shares at a weighted average price of $59.59, leaving 412,105 shares beneficially owned.
The filing states the trades were executed pursuant to a 10b5-1 plan adopted in 2024 and discloses weighted average price ranges for the transactions. The form is signed by an attorney-in-fact on behalf of the reporting person.
Positive
- Transactions executed under a Rule 10b5-1 plan, indicating pre-established trading intent rather than opportunistic insider timing.
- Reporting includes weighted-average price ranges and an undertaking to supply per-price details on request, supporting transparency.
Negative
- Insider sold 5,392 shares across two days, reducing beneficial ownership from 413,605 to 412,105 shares, which may be perceived negatively by some investors.
Insights
TL;DR Insider sold a small portion of holdings under a pre-established 10b5-1 plan; remaining stake remains large.
The reported transactions consist of 5,392 shares sold across two days for weighted average prices near $59.50–$59.69, reducing beneficial ownership from 418,497 (implicit) to 412,105 shares. Sales executed under a 2024 Rule 10b5-1 plan indicate pre-arranged disposition rather than ad hoc liquidation. For investors, these are routine insider sales and do not, by themselves, provide evidence of company-specific negative information. The filing includes undertaking to provide detailed per-price breakdowns on request, which supports transparency.
TL;DR Disclosure follows standard practices: 10b5-1 plan cited and attorney-in-fact signature present.
The Form 4 properly identifies the reporting person, relationship to issuer (Officer, CFO and COO), transaction dates, codes and weighted-average prices, and documents that the sale was pursuant to a 10b5-1 plan adopted in 2024. The explicit offer to provide per-price sale details on request aligns with good disclosure practice. No amendments or additional executive actions are disclosed in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, par value $0.001 per share | 1,500 | $59.59 | $89K |
| Sale | Common Stock, par value $0.001 per share | 3,892 | $59.52 | $232K |
Footnotes (1)
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.50 to $59.60, inclusive. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer, or a shareholder of the Issuer full information regarding the number of shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.50 to $59.69, inclusive. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer, or a shareholder of the Issuer full information regarding the number of shares sold at each separate price.
FAQ
What transactions did Guy Melamed report on Form 4 for VRNS?
Were the sales by the VRNS officer part of a pre-arranged plan?
Does the Form 4 provide exact per-transaction prices for the sales?
Who signed the Form 4 filing for Guy Melamed?